Q3 2018 13F Holders as of 9/30/2018
-
Type / Class
-
Equity / ISHARES BIOTECH
-
Number of holders
-
626
-
Total shares
-
51.6M
-
Shares change
-
-4.49M
-
Total reported value, excl. options
-
$6.29B
-
Value change
-
-$538M
-
Put/Call ratio
-
1.77
-
Number of buys
-
256
-
Number of sells
-
-250
-
Price
-
$121.94
Significant Holders of ISHARES TR - ISHARES BIOTECH (IBB) as of Q3 2018
672 filings reported holding IBB - ISHARES TR - ISHARES BIOTECH as of Q3 2018.
ISHARES TR - ISHARES BIOTECH (IBB) has 626 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 51.6M shares
.
Largest 10 shareholders include BANK OF AMERICA CORP /DE/ (14.1M shares), MORGAN STANLEY (4.03M shares), UBS Group AG (3.61M shares), CITIGROUP INC (2.54M shares), GOLDMAN SACHS GROUP INC (2.12M shares), BNP PARIBAS ARBITRAGE, SA (1.94M shares), DEUTSCHE BANK AG\ (1.88M shares), Duquesne Family Office LLC (1.03M shares), ROYAL BANK OF CANADA (772K shares), and WELLS FARGO & COMPANY/MN (769K shares).
This table shows the top 626 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.